Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study.

Conclusion Analysis of bowel microvascularization by CEUS shows statistically significant changes in the wash-in-rate related to response of vedolizumab therapy.
PMID: 29345146 [PubMed - as supplied by publisher]

Source: Acta Radiologica - January 1, 2018 Category: Radiology Authors: Goertz RS, Klett D, Wildner D, Atreya R, Neurath MF, Strobel D Tags: Acta Radiol Source Type: research